Home Pain Management Scientists move closer to regrowing joints

Scientists move closer to regrowing joints

Credit: Unsplash+

A new wave of research is giving hope to millions of people living with arthritis. Scientists are now working on treatments that may not only reduce pain, but actually repair damaged joints.

Osteoarthritis is the most common type of arthritis. It affects about 32 million people in the United States alone and many more around the world. The condition happens when the protective cartilage in joints slowly wears away over time.

Cartilage is a smooth tissue that helps bones move easily against each other. When it breaks down, bones begin to rub together, causing pain, stiffness, and reduced movement.

For many years, treatment options for osteoarthritis have been limited. Doctors usually focus on managing symptoms. This may include pain relief, physical therapy, or eventually joint replacement surgery. However, these approaches do not fix the underlying damage.

Now, researchers supported by the Advanced Research Projects Agency for Health are exploring new ways to treat the root cause of the disease. Their work focuses on helping the body repair or even regrow cartilage and bone.

The research involves three major teams from leading universities. Scientists at Duke University and the University of Colorado Boulder are developing treatments that can be injected directly into the joint. These treatments aim to stimulate the body’s own repair systems.

One approach uses a special drug that stays inside the joint and slowly releases over time. This helps create the right conditions for damaged tissue to heal. Another method uses proteins that fill in worn areas and signal the body to rebuild cartilage.

A third team at Columbia University is working on a more advanced idea. They are developing a way to regrow an entire knee joint using a 3D-printed structure. This structure acts as a framework where new bone and cartilage cells can grow and form a new joint.

So far, these treatments have only been tested in small animals. Early results are encouraging, with some studies showing that cartilage can regrow within a few months. However, results in animals do not always match what happens in humans, so further testing is needed.

Experts who are not involved in the research say the work is very promising. Current treatments mostly help manage pain but do not stop the disease from progressing. A treatment that can rebuild cartilage and bone could change how osteoarthritis is treated in the future.

There is also excitement about how quickly these projects are moving forward. The research teams are expected to begin testing their treatments in human patients within about 18 months. This is faster than many traditional medical research timelines.

The project has received strong financial support. Tens of millions of dollars have been invested to speed up development. One team alone has received more than $42 million to support its work.

If these treatments are successful, there are plans to make them widely available. The goal is to keep the cost affordable, at no more than 25% of current treatment costs. This could make advanced care accessible to more patients.

However, it is still early in the process. More research is needed to confirm that these treatments are safe and effective in people. There may also be challenges in scaling up production and ensuring long-term results.

Overall, this research represents an exciting step forward. It shows a shift from treating symptoms to repairing damage. If successful, these new therapies could greatly improve quality of life for people with arthritis and reduce the need for major surgeries.

If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.

For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.

Source: Advanced Research Projects Agency for Health.